about
Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional studyEfficacy of Berberine in Patients with Non-Alcoholic Fatty Liver DiseaseHypokalemia, hypomagnesemia, hypocalciuria, and recurrent tetany: Gitelman syndrome in a Chinese pedigree and literature review.Liver fat content, evaluated through semi-quantitative ultrasound measurement, is associated with impaired glucose profiles: a community-based study in ChineseSerum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional studyLiver Fat Content Is Associated with Elevated Serum Uric Acid in the Chinese Middle-Aged and Elderly Populations: Shanghai Changfeng Study.Vitamin D Levels Are Inversely Associated with Liver Fat Content and Risk of Non-Alcoholic Fatty Liver Disease in a Chinese Middle-Aged and Elderly Population: The Shanghai Changfeng StudyInfluence of Ethnicity on the Accuracy of Non-Invasive Scores Predicting Non-Alcoholic Fatty Liver Disease.The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.The association of liver fat content and serum alanine aminotransferase with bone mineral density in middle-aged and elderly Chinese men and postmenopausal women.Serum retinol binding protein 4 is negatively related to estrogen in Chinese women with obesity: a cross-sectional study.Lipid profiling of the therapeutic effects of berberine in patients with nonalcoholic fatty liver disease.Serum retinol binding protein 4 is negatively related to beta cell function in Chinese women with non-alcoholic fatty liver disease: a cross-sectional studyA indicator of visceral adipose dysfunction to evaluate metabolic health in adult Chinese.Effect of age on the diagnostic efficiency of HbA1c for diabetes in a Chinese middle-aged and elderly population: The Shanghai Changfeng Study.[Relationship between liver fat content and liver enzymes in individuals with various statuses of glucose metabolism].Optimal Vitamin D Status in a Middle-Aged and Elderly Population Residing in Shanghai, China.Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21.I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.Metformin attenuates triglyceride accumulation in HepG2 cells through decreasing stearyl-coenzyme A desaturase 1 expression.Berberine promotes the recruitment and activation of brown adipose tissue in mice and humans.Elevation of liver enzymes within the normal limits and metabolic syndromeCold water stress attenuates dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in miceRenal function-dependent association of serum uric acid with metabolic syndrome and hepatic fat content in a middle-aged and elderly Chinese populationSerum folic acid levels are associated with the presence and severity of liver steatosis in Chinese adultsAssociation of visceral adiposity and its longitudinal increase with the risk of diabetes in Chinese adults: A prospective cohort studyThe PNPLA3 rs738409 C>G variant interacts with changes in body weight over time to aggravate liver steatosis, but reduces the risk of incident type 2 diabetesDynamic changes in the distribution of facial and abdominal adipose tissue correlated with surgical treatment in acromegalyNAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD TreatmentThe PNPLA3 rs738409 C>G variant influences the association between low skeletal muscle mass and NAFLD: the Shanghai Changfeng StudyPreoperative Thyroid Autoimmune Status and Changes in Thyroid Function and Body Weight After Bariatric Surgery
P50
Q21135215-003F8C35-EB7F-4E14-AFC9-CBCF2CCFC0A0Q27301440-615FCBB7-507B-4EAA-9258-1766068EA028Q33625736-6177FB45-E863-4E93-A0B0-83B02A3F3AF8Q34811955-3A02F9E1-5616-4976-8840-06DDB26C6820Q35568925-60B47270-6FEE-466A-87EA-27B3966A30E6Q35810113-948E22C6-6C56-4927-A334-45407E4D348AQ36047914-09949E0C-7156-4218-BCFC-0B653B471127Q36118420-D2A899E1-1AF6-4BBE-8E8D-278340C608AAQ36329123-FA4193B2-1E98-4D42-9BDF-EBC6748D7C5FQ36485944-25340B00-79C0-42C9-B58C-A91EEEDE6C6BQ36668250-B42E26BE-9627-4E0A-A5C6-7D5BD8974DEEQ37258198-C80431D9-8E7D-4DB8-AE51-7ECC8DDF95C8Q37418334-B8D0BB7E-5B0C-41DB-BD2E-2A7392B674A7Q37459919-D25CC5F3-62F9-4635-AE98-B8D828E582B1Q41488749-5503DA5D-912A-4A51-B9E7-00FB3530229FQ42759189-68FD9987-D10C-49A3-9E36-68634C633D8BQ47115709-AF46DD1F-71C6-4F31-B05F-1303D80013B4Q47610112-141B853F-2A20-4868-8F04-98424E5D352BQ50241143-4CACF75C-46E8-4012-95FD-D9924BE79549Q54979135-2D7CCFF5-BDEA-4293-9118-ED3DF9BA68F7Q64882811-9968DC23-978B-49D3-924A-113F2A31DF77Q83647232-B26B026A-14DB-4195-BC96-2858F4CD7907Q84072580-AAEB28C5-5F70-4318-9286-3AB1BC7C37B8Q85012817-B403D1FA-8D3C-43E4-B2B3-6C6726061D77Q88513134-8299A6AE-351C-472E-8071-4A0AE71B1074Q90411705-ED268E74-FC88-4FF8-938B-A95E55791430Q91182416-E37DF368-2EBA-4246-AB0C-15729FA44381Q91375632-A57965A2-7761-4829-B666-D72CAD0E4C8CQ92856739-19BEED4D-78D8-49E7-B96B-A29B5BAFB251Q93095422-60ADE743-50CA-48D4-8545-D88AE044EC97Q93133467-34220DD4-4E7C-4AC9-A64A-EC65AF436373
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0002-5650-0165
@en
name
Ming-Feng Xia
@ast
Ming-Feng Xia
@en
Ming-Feng Xia
@es
Ming-Feng Xia
@nl
type
label
Ming-Feng Xia
@ast
Ming-Feng Xia
@en
Ming-Feng Xia
@es
Ming-Feng Xia
@nl
prefLabel
Ming-Feng Xia
@ast
Ming-Feng Xia
@en
Ming-Feng Xia
@es
Ming-Feng Xia
@nl
P106
P31
P496
0000-0002-5650-0165